The Scientist

» ebola, genetics & genomics and neuroscience

Most Recent

image: <em>TS</em> Picks: May 7, 2015

TS Picks: May 7, 2015

By | May 7, 2015

Genetics & genomics edition

0 Comments

image: Mouse Mind Control

Mouse Mind Control

By | May 4, 2015

Genetics & genomics edition

1 Comment

image: Capsule Reviews

Capsule Reviews

By | May 1, 2015

Genetics & genomics edition

0 Comments

image: Looking for Latent HIV

Looking for Latent HIV

By | May 1, 2015

Genetics & genomics edition

0 Comments

image: Targeted Information in the Rat Brain

Targeted Information in the Rat Brain

By | April 30, 2015

Genetics & genomics edition

0 Comments

image: Study Participants Want to Know

Study Participants Want to Know

By | April 29, 2015

Genetics & genomics edition

0 Comments

image: Combatting Viruses with RNA-Targeted CRISPR

Combatting Viruses with RNA-Targeted CRISPR

By | April 27, 2015

Genetics & genomics edition

0 Comments

image: One-Man Tinnitus Map

One-Man Tinnitus Map

By | April 26, 2015

Genetics & genomics edition

0 Comments

image: RNA Ebola Drug Clears Animal Study

RNA Ebola Drug Clears Animal Study

By | April 24, 2015

Genetics & genomics edition

0 Comments

image: Mosquitoes Play Genetic Favorites

Mosquitoes Play Genetic Favorites

By | April 23, 2015

Genetics & genomics edition

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech